Charcot-Marie-Tooth Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Electrophysiologically, at least two types of CMT can be distinguished; CMT1 which has decreased nerve conduction velocities (NCV) and CMT2 which has normal or near normal NCV with decreased amplitudes.
|
1341967 |
1992 |
Hereditary Motor and Sensory Neuropathies
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The distal HMN shows similarities with the hereditary motor and sensory neuropathies type I and II (HMSN I and HMSN II) or Charcot-Marie-Tooth disease type 1 and 2 (CMT 1 and CMT 2) and with some proximal HMN or spinal muscular atrophies (SMA).
|
1517763 |
1992 |
Hereditary Motor and Sensory-Neuropathy Type II
|
0.020 |
Biomarker
|
disease |
BEFREE |
The distal HMN shows similarities with the hereditary motor and sensory neuropathies type I and II (HMSN I and HMSN II) or Charcot-Marie-Tooth disease type 1 and 2 (CMT 1 and CMT 2) and with some proximal HMN or spinal muscular atrophies (SMA).
|
1517763 |
1992 |
Hereditary Motor and Sensory Neuropathy Type I
|
0.020 |
Biomarker
|
disease |
BEFREE |
The distal HMN shows similarities with the hereditary motor and sensory neuropathies type I and II (HMSN I and HMSN II) or Charcot-Marie-Tooth disease type 1 and 2 (CMT 1 and CMT 2) and with some proximal HMN or spinal muscular atrophies (SMA).
|
1517763 |
1992 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The present study therefore provides evidence for genetic heterogeneity between the hypertrophic and the neuronal forms of Charcot-Marie-Tooth disease and demonstrates that the CMT2 gene is not allelic to either of the CMT1 genes mapped to date.
|
1733853 |
1992 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Localization of X-linked dominant Charcot-Marie-Tooth disease (CMT 2) to Xq13.
|
3462379 |
1986 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The neuronal form of this disorder is referred to as Charcot-Marie-Tooth type II disease (CMT2).
|
7573046 |
1995 |
Axonal neuropathy
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
CMT2 is usually inherited as an autosomal dominant trait with a variable age at onset of symptoms associated with progressive axonal neuropathy.
|
7573046 |
1995 |
Axonal neuropathy
|
0.080 |
Biomarker
|
disease |
BEFREE |
CMT2 is an axonal neuropathy of undetermined cause.
|
7804455 |
1994 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth neuropathy type II (CMT2) is an axonal neuropathy, also of undetermined cause.
|
7849745 |
1994 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Charcot-Marie-Tooth neuropathy type II (CMT2) is an axonal neuropathy, also of undetermined cause.
|
7849745 |
1994 |
Axonal neuropathy
|
0.080 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth neuropathy type II (CMT2) is an axonal neuropathy, also of undetermined cause.
|
7849745 |
1994 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Twelve CMT patients who did not have decreased nerve conduction velocities consistent with a diagnosis of CMT type 2 (CMT2) were found not to have the CMT1A duplication.
|
8105684 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Two major types can be distinguished based on electrophysiologic phenotypes: CMT type 1 (CMT1) displays uniformly decreased nerve conduction velocity associated with a demyelinating hypertrophic neuropathy, and CMT type 2 (CMT2) displays normal or near-normal nerve conduction velocity associated with a neuronal defect.
|
8128981 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genetic heterogeneity within the most common genetic neuropathy, Charcot-Marie-Tooth disease (CMT) results in about 70% slow nerve conduction CMT1 and 30% normal nerve conduction CMT2.
|
8135298 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
CMT2 is pathologically and genetically distinct from CMT type 1 (CMT1).
|
8406488 |
1993 |
Inherited Peripheral Neuropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth (CMT) disease type 2 (CMT2) is an inherited peripheral neuropathy characterized by variable age of onset and normal or slightly diminished nerve conduction velocity.
|
8406488 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The other CMT families with dominant inheritance but without duplication included one family with CMT1B (demyelinating CMT mapped on chromosome 1) (1.6%), 14 families with CMT2 axonal neuropathy (22.2%), and 10 families with X-linked dominant CMT (15.9%).
|
8413376 |
1993 |
Charcot-Marie-Tooth Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth neuropathy type 2 (CMT2) is a common inherited axonal neuropathy.
|
8614538 |
1996 |
Axonal neuropathy
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth neuropathy type 2 (CMT2) is a common inherited axonal neuropathy.
|
8614538 |
1996 |
Charcot-Marie-Tooth disease, Type 2A
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the CMT2A locus is a minor locus for CMT2, additional linkage studies are needed to localize other CMT2 loci, and Cx32 mutations may be the underlying genetic defect in some CMT2 families.
|
8628473 |
1996 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical, electrophysiological and genetic linkage studies were performed on a large autosomal dominant family with Charcot-Marie-Tooth axonal neuropathy type 2 (CMT2) with 38 members of which 14 were affected.
|
8872480 |
1996 |
Charcot-Marie-Tooth Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Point mutations in the coding region of the myelin genes, peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) or connexin 32 (Cx32) have been reported in CMT patients, including CMT type 1 (CMT1), CMT type 2 (CMT2) and Déjérine-Sottas neuropathy (DS) patients, and only in the coding region of PMP22 in HNPP families lacking a deletion.
|
9187667 |
1997 |
Dejerine-Sottas Disease (disorder)
|
0.030 |
Biomarker
|
disease |
BEFREE |
Point mutations in the coding region of the myelin genes, peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) or connexin 32 (Cx32) have been reported in CMT patients, including CMT type 1 (CMT1), CMT type 2 (CMT2) and Déjérine-Sottas neuropathy (DS) patients, and only in the coding region of PMP22 in HNPP families lacking a deletion.
|
9187667 |
1997 |
Hereditary liability to pressure palsies
|
0.030 |
Biomarker
|
disease |
BEFREE |
Point mutations in the coding region of the myelin genes, peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ) or connexin 32 (Cx32) have been reported in CMT patients, including CMT type 1 (CMT1), CMT type 2 (CMT2) and Déjérine-Sottas neuropathy (DS) patients, and only in the coding region of PMP22 in HNPP families lacking a deletion.
|
9187667 |
1997 |